Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma von Gribben, John G, Fowler, Nathan, Morschhauser, Franck

Volltext

How and when I do allogeneic transplant in CLL von Gribben, John G.

Volltext

Targeting the methylome to improve CLL outcome von Gribben, John G.

Volltext

Practical management of tumour lysis syndrome in venetoclax‐treated patients with chronic lymphocytic leukaemia von Gribben, John G.

Volltext

How I treat CLL up front von Gribben, John G.

Volltext

The role of B7 family molecules in hematologic malignancy von Greaves, Paul, Gribben, John G.

Volltext

Loss of 5-hydroxymethylcytosine in cancer: Cause or consequence? von Ficz, Gabriella, Gribben, John G.

Volltext

To start and stop or just keep going? von Gribben, John G.

Volltext

The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies von Burger, Jan A, Gribben, John G

Volltext

Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice von Gribben, John G., Bosch, Francesc, Cymbalista, Florence, Geisler, Christian H., Ghia, Paolo, Hillmen, Peter, Moreno, Carol, Stilgenbauer, Stephan

Volltext

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma von Leonard, John P, Trneny, Marek, Izutsu, Koji, Fowler, Nathan H, Hong, Xiaonan, Zhu, Jun, Zhang, Huilai, Offner, Fritz, Scheliga, Adriana, Nowakowski, Grzegorz S, Pinto, Antonio, Re, Francesca, Fogliatto, Laura Maria, Scheinberg, Phillip, Flinn, Ian W, Moreira, Claudia, Cabeçadas, José, Liu, David, Kalambakas, Stacey, Fustier, Pierre, Wu, Chengqing, Gribben, John G

Volltext

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study von Hillmen, Peter, Rawstron, Andy C, Brock, Kristian, Muñoz-Vicente, Samuel, Yates, Francesca J, Bishop, Rebecca, Boucher, Rebecca, MacDonald, Donald, Fegan, Christopher, McCaig, Alison, Schuh, Anna, Pettitt, Andrew, Gribben, John G, Patten, Piers E M, Devereux, Stephen, Bloor, Adrian, Fox, Christopher P, Forconi, Francesco, Munir, Talha

Volltext

PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia von McClanahan, Fabienne, Hanna, Bola, Miller, Shaun, Clear, Andrew James, Lichter, Peter, Gribben, John G., Seiffert, Martina

Volltext

Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma von Araf, Shamzah, Wang, Jun, Korfi, Koorosh, Pangault, Celine, Kotsiou, Eleni, Rio-Machin, Ana, Rahim, Tahrima, Heward, James, Clear, Andrew, Iqbal, Sameena, Davies, Jeff K., Johnson, Peter, Calaminici, Maria, Montoto, Silvia, Auer, Rebecca, Chelala, Claude, Gribben, John G., Graham, Trevor A., Fest, Thierry, Fitzgibbon, Jude, Okosun, Jessica

Volltext

Do we need to analyse everything at diagnosis in chronic lymphocytic leukaemia? von Gribben, John G.

Volltext

Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible imm... von Ramsay, Alan G., Clear, Andrew J., Fatah, Rewas, Gribben, John G.

Volltext

First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE... von Moreno, Carol, Greil, Richard, Demirkan, Fatih, Tedeschi, Alessandra, Anz, Bertrand, Larratt, Loree, Simkovic, Martin, Novak, Jan, Strugov, Vladimir, Gill, Devinder, Gribben, John G, Kwei, Kevin, Dai, Sandra, Hsu, Emily, Dean, James P, Flinn, Ian W

Volltext

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phas... von Moreno, Carol, Greil, Richard, Demirkan, Fatih, Tedeschi, Alessandra, Anz, Bertrand, Larratt, Loree, Simkovic, Martin, Samoilova, Olga, Novak, Jan, Ben-Yehuda, Dina, Strugov, Vladimir, Gill, Devinder, Gribben, John G, Hsu, Emily, Lih, Chih-Jian, Zhou, Cathy, Clow, Fong, James, Danelle F, Styles, Lori, Flinn, Ian W

Volltext

Bone marrow niches in haematological malignancies von Méndez-Ferrer, Simón, Bonnet, Dominique, Steensma, David P., Hasserjian, Robert P., Ghobrial, Irene M., Gribben, John G., Andreeff , Michael, Krause, Daniela S.

Volltext

Update on Therapy of Chronic Lymphocytic Leukemia von Gribben, John G., O'Brien, Susan

Volltext